2VVN
BtGH84 in complex with NH-Butylthiazoline
2VVN の概要
| エントリーDOI | 10.2210/pdb2vvn/pdb |
| 関連するPDBエントリー | 2CHN 2CHO 2J47 2J4G 2JIW |
| 分子名称 | O-GLCNACASE BT_4395, GLYCEROL, AMMONIUM ION, ... (5 entities in total) |
| 機能のキーワード | glycoside hydrolase, complex, hydrolase, inhibitor, glycosidase |
| 由来する生物種 | BACTEROIDES THETAIOTAOMICRON |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 169782.57 |
| 構造登録者 | |
| 主引用文献 | Yuzwa, S.A.,Macauley, M.S.,Heinonen, J.E.,Shan, X.,Dennis, R.J.,He, Y.,Whitworth, G.E.,Stubbs, K.A.,Mceachern, E.J.,Davies, G.J.,Vocadlo, D.J. A Potent Mechanism-Inspired O-Glcnacase Inhibitor that Blocks Phosphorylation of Tau in Vivo. Nat.Chem.Biol., 4:483-, 2008 Cited by PubMed Abstract: Pathological hyperphosphorylation of the microtubule-associated protein tau is characteristic of Alzheimer's disease (AD) and the associated tauopathies. The reciprocal relationship between phosphorylation and O-GlcNAc modification of tau and reductions in O-GlcNAc levels on tau in AD brain offers motivation for the generation of potent and selective inhibitors that can effectively enhance O-GlcNAc in vertebrate brain. We describe the rational design and synthesis of such an inhibitor (thiamet-G, K(i) = 21 nM; 1) of human O-GlcNAcase. Thiamet-G decreased phosphorylation of tau in PC-12 cells at pathologically relevant sites including Thr231 and Ser396. Thiamet-G also efficiently reduced phosphorylation of tau at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus, which reveals the rapid and dynamic relationship between O-GlcNAc and phosphorylation of tau in vivo. We anticipate that thiamet-G will find wide use in probing the functional role of O-GlcNAc in vertebrate brain, and it may also offer a route to blocking pathological hyperphosphorylation of tau in AD. PubMed: 18587388DOI: 10.1038/NCHEMBIO.96 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.85 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






